TreeFrog Therapeutics
treefrog.fr
Actively hiring
Health Care
Regenerative Medicine
Cell & Gene Therapy
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$32.4M
1 round on record
Latest round
$32.4M
Venture round · May 2025 · 16 mo ago
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 27, 2025
Raised a round Venture round $32.4M · YahooFinance
Feb 15, 2023
Partnership GAIA BioMedicine and TreeFrog Therapeutics Announce Collaboration for the Expansion of Allogeneic NK-like Cells Against Solid Tumors · YahooFinance
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2025 | $32.4M | — | YahooFinance |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.
Healshape is a regenerative medicine company that develops a 100% natural, personalized and resorbable bioprosthesis for breast…
We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Acorn is a personalized regenerative medicine company, helping people preserve their own cells to prepare for the future of cell-based…
News
TFG-001: 3D Neural Microtissue Cell Therapy for Parkinson's Disease: new preclinical data presented at the 7th World Parkinson Congress in Phoenix, Arizona
- TreeFrog Therapeutics presented new preclinical data on its lead program, TFG-001, a 3D Neural Microtissue Cell Therapy for Parkinson's Disease at the World Parkinson Congress on May 27. - BORDEAUX, France / May 28th, 2026 - TreeFrog Therapeutics, a reg
Read more
Report
TFG-001, A NOVEL 3D NEURAL MICROTISSUE CELL THERAPY, DEMONSTRATES SUPERIOR FUNCTIONALITY AND REINNERVATION FOR PARKINSON'S DISEASE
BORDEAUX, France - May 25, 2026 - TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson's Conference. TFG-0
Read more
Report
In the Stem Cell Jungle #3
Welcome to the third edition of our factsheets. Here we dive in to discuss the distinct approaches and mechanisms of action of gene versus cell therapy. TreeFrog_Infographic3_V2_AF_3Download The post In the Stem Cell Jungle #3 appeared first on TreeFrog T
Read more
Report
In the Stem Cell Jungle #2
In factsheet one, we introduced cell therapy and the immense potential it has to help millions of patients suffering from diseases such as neurodegenerative diseases and those of the major organs. In our second factsheet, we look at some of the major chal
Read more
Report
In the Stem Cell Jungle #1 Factsheet
Regenerative medicine holds huge promise for the future and the recent approvals of the first iPSC-derived cell therapies (in Parkinson's disease and heart failure) are fruits of decades of research, incremental steps and large leaps !At TreeFrog, we thou
Read more
Report
TREEFROG THERAPEUTICS ANNOUNCES CHANGES TO EXECUTIVE COMMITTEE WITH THE ARRIVAL OF MARK ROTHERA AS CHIEF EXECUTIVE OFFICER & BOARD MEMBER TO SPEARHEAD NEXT PHASE OF GROWTH
BORDEAUX, December 16th, 2025 - TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem is delighted to announce the appointment of skilled biotech leader, Mark Rother
Read more
Report
TreeFrog Therapeutics
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for TreeFrog Therapeutics reflects the research output of authors from TreeFrog Therapeutics who published articles in the 145 journals in
Read more
Report
TREEFROG THERAPEUTICS SECURES €30 MILLION FROM EUROPEAN INVESTMENT BANK (EIB) MARKING A SIGNIFICANT MILESTONE IN THE COMPANY'S JOURNEY TO ACCELERATE THE FIELD OF CELL THERAPY
€30 million financing with mix of dilutive and venture debt financing Funds to advance Parkinson's disease cell therapy program to the clinic and further develop their internal pipeline of cell therapies Deal benefits from guarantee under European Commiss
Read more
Report
TreeFrog Therapeutics Secures €30 Million From European Investment Bank (EIB) Marking a Significant Milestone in the Company's Journey to Accelerate the Field of Cell Therapy
BORDEAUX, France, May 27, 2025--TreeFrog Therapeutics secures 30million EUR from the European Investment Bank to accelerate the field of cell therapy
Read more
Report
Report
Show more news
Financials
Total raised
$32.4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $32.4M | Details |